0001727477-23-000003.txt : 20230911
0001727477-23-000003.hdr.sgml : 20230911
20230911122747
ACCESSION NUMBER: 0001727477-23-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230908
FILED AS OF DATE: 20230911
DATE AS OF CHANGE: 20230911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Voigtlander Christian B.
CENTRAL INDEX KEY: 0001727477
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 231247244
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2023-09-08
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001727477
Voigtlander Christian B.
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
Chief Operating Officer
0
Common Stock
2023-09-08
4
S
0
6162
128.9735
D
14291
D
Common Stock
2023-09-08
4
S
0
688
129.6444
D
13603
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.54 to $129.48, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.60 to $129.91, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
By: Paula Darbyshire, Attorney-in-fact For: Christian B. Voigtlander
2023-09-11